Phase 2 and 3 DCTs exhibited numerically shorter mean durations (17.3 vs 18.3 months; 23.4 vs 25.0 months), but these differences did not reach statistical significance ( p §amp;gt; 0.05 ).
← all excerpts
Association between decentralised clinical trial adoption and trial duration: a retrospective cross-sectional study of metabolic disease trials.
1
—
—